Apoptosis induced by nonspecific effects of siRNA in human umbilical vein endothelial cell

Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998).

Sharp, P. A. RNA interference-2001. Genes Dev. 15: 485–490 (2001).

Bernstein, E. et al. Dicer is essential for mouse development. Nat. Genet. 35, 215–217 (2003).

Hannon, G. J. RNA interference. Nature 418, 244–251 (2002).

Persengiev, S. P., Zhu, X. & Green, M. R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12–18 (2004).

Alexopoulou, L., Holt, A. C. Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732–738 (2001).

Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).

Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).

Jacque, J. M., Triques, K. & Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 418, 435–438 (2002).

Kim, D. H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321–325 (2004).

Sledz, C. A. et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839 (2003).

Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545–6549 (2004).

Faure, E. et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275, 11058–11063 (2000).

de Kleijn, D. & Pasterkamp, G. Toll-like receptors in cardiovascular diseases. Cardiovasc. Res. 60, 58–67 (2003).

Donze, O. & Picard, D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 30, e46 (2002).

Oshiumi, H. et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferonbeta induction. Nat. Immunol. 4, 161–167 (2003).

Cook, D. N., Pisetsky, D. S. & Schwartz, D. A. Tolllike receptors in the pathogenesis of human disease. Nat. Immunol. 5, 975–979 (2004).

Matsumoto, M. et al. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364–1369 (2002).

Wang, Q. & Carmichael, G. G. Effects of length and location on the cellular response to double-stranded RNA. Microbiol. Mol. Biol. Rev. 68, 432–452 (2004).

Bridge, A. J. et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263–264 (2003).

McAllister, C. S. & Samuel, C. E. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J. Biol. Chem. 284, 1644–1651 (2009).

Reynolds, A. et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12, 988–993 (2006).

Siolas, D. et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23, 227–231 (2005).

Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778–809, table of contents (2001).

Bevilacqua, P. C., George, C. X., Samuel, C. E. & Cech, T. R. Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry 37, 6303–6316 (1998).

Zhang, P. & Samuel, C. E. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 81, 8192–8200 (2007).

Gil, J. & Esteban, M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5, 107–114 (2000).

Tschaharganeh, D. et al. Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol. Oncol. Res. 13, 84–90 (2007).